Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch.
Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch.
批准号:
DP1093281
负责人:
Prof Mark Kendall
金额:
$57.48万
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-05-15 至 2012-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Vaccination protects us from infections like measles and flu. In principle, it could protect us from all diseases, even from skin cancer and arthritis. In practice, however, vaccines to diseases like cancer have largely proved ineffective. One problem is that we don't really understand how the body's immune system responds to vaccination. Our aim, therefore, is to investigate changes in the immune system when a vaccine enters the skin, as might happen by injection. Experimenting with laboratory mice and a special vaccine-injecting Nanopatch that is attached to each mouse's ear, we are starting to understand how a vaccine affects the immune cells in the skin. In the future we plan to apply this knowledge to improve vaccination in people.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Specific targeting of nanosystems by cutaneous delivery
-
批准号:nhmrc : 1049906
-
项目类别:Project Grants
-
资助金额:$65.68万
-
财政年份:2013
-
负责人:Prof Mark Kendall
-
依托单位:
Investigating a novel, physical adjuvant for improving immune responses of vaccines
-
批准号:LP130100882
-
项目类别:Linkage Projects
-
资助金额:$42.8万
-
财政年份:2013
-
负责人:Prof Mark Kendall
-
依托单位:
Optimising the body's immune response with a Nanopatch that delivers biomolecules to the skin
-
批准号:FT0991982
-
项目类别:ARC Future Fellowships
-
资助金额:$63.57万
-
财政年份:2010
-
负责人:Prof Mark Kendall
-
依托单位:
MPM non-invasive imaging of biological interactions following drug delivery with micro-nanoprojection patches.
-
批准号:nhmrc : 456150
-
项目类别:NHMRC Project Grants
-
资助金额:$26.91万
-
财政年份:2007
-
负责人:Prof Mark Kendall
-
依托单位:
Micro-nanoprojection patches for minimally-invasive and targeted delivery of genes and drugs to skin cells: from concept to technology platform
-
批准号:DP0774647
-
项目类别:Discovery Projects
-
资助金额:$46.83万
-
财政年份:2007
-
负责人:Prof Mark Kendall
-
依托单位:
国内基金
海外基金
登录
查看更多内容
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
间充质干细胞通过CD73/CD39/腺苷-PI3K/Akt-Nrf2信号轴调节CD4+IL-10+IFN-γ+T细胞分化减弱GVHD机制研究
-
批准号:32070781
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:栾希英
-
依托单位:
MET通过MTOR介导的自噬调节肝癌免疫原性和治疗抗性的作用及机制研究
-
批准号:31970696
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:黄星
-
依托单位: